Immune thrombocytopenia
Showing 1 - 25 of >10,000
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023
Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)
Recruiting
- Immune Thrombocytopenia Purpura
- Dexamethasone
- +4 more
-
Cairo, EgyptEL-Kasr elineiy
May 6, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023
ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)
Not yet recruiting
- ITP - Immune Thrombocytopenia
- hetrombopag 5mg po qd
- High-dose Dexamethasone
- (no location specified)
Jul 5, 2023
Pediatric Primary Immune Thrombocytopenia (ITP)
Recruiting
- Primary Immune Thrombocytopenia
- data collection
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023
Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)
Not yet recruiting
- Primary Immune Thrombocytopenia (ITP)
- Ianalumab
- (no location specified)
Jun 5, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (CM313 Injection)
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- CM313 Injection
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 12, 2023
Primary Immune Thrombocytopenia Trial in Shandong (QL0911, Placebo comparator)
Completed
- Primary Immune Thrombocytopenia
- QL0911
- Placebo comparator
-
Shandong, ChinaQilu Hospital of Shandong University
Nov 20, 2022
Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)
Recruiting
- Primary Immune Thrombocytopenia (ITP)
- Ianalumab
- +2 more
-
Singapore, SingaporeNovartis Investigative Site
Jan 17, 2023
Relapsed/Refractory Immune Thrombocytopenia Trial in Seoul (Bortezomib)
Not yet recruiting
- Relapsed/Refractory Immune Thrombocytopenia
-
Seoul, Korea, Republic of
- +1 more
Oct 30, 2022
ITP, Immune Thrombocytopenia Trial in Beijing (Baricitinib)
Recruiting
- ITP
- Immune Thrombocytopenia
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Sep 27, 2022
Immune Markers in Pediatric ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
- (no location specified)
Oct 17, 2023
Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,
Recruiting
- Autoimmune Hemolytic Anemia
- +5 more
- cytokine essays
- +6 more
-
Milano, ItalyFondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023
Immune Thrombocytopenia Trial (Daratumumab Injection)
Not yet recruiting
- Immune Thrombocytopenia
- Daratumumab Injection
- (no location specified)
Sep 28, 2022
Immune Thrombocytopenia Trial in Bristol (Mycophenolate Mofetil, Prednisolone)
Completed
- Immune Thrombocytopenia
- Mycophenolate Mofetil
- Prednisolone
-
Bristol, United KingdomUniversity Hospital Bristol NHS Foundation Trust
Oct 25, 2022
Immune Thrombocytopenia Trial (peripheral blood and bone marrow withdrawal)
Not yet recruiting
- Immune Thrombocytopenia
- peripheral blood and bone marrow withdrawal
- (no location specified)
Jan 12, 2023
Primary Immune Thrombocytopenia Trial in Singapore (Ianalumab, Eltrombopag, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- Ianalumab
- +2 more
-
Singapore, SingaporeNovartis Investigative Site
Jan 23, 2023
Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG, Dexamethasone)
Recruiting
- Immune Thrombocytopenia
- Baricitinib 2 MG
- Dexamethasone
-
Beijing, China
- +9 more
Jul 11, 2023
Immune Thrombocytopenia Trial in Beijing (Cyclosporine Oral Product, Prednisone)
Not yet recruiting
- Immune Thrombocytopenia
- Cyclosporine Oral Product
- Prednisone
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Jul 14, 2022
Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura
Not yet recruiting
- ITP - Immune Thrombocytopenia
- eltrombopag and romiplastim
- (no location specified)
Nov 16, 2023
Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG [Olumiant], Danazol)
Not yet recruiting
- Immune Thrombocytopenia
- Baricitinib 2 MG [Olumiant]
- Danazol
-
Beijing, Beijing, China
- +9 more
May 2, 2023
Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)
Enrolling by invitation
- Refractory Systemic Lupus Erythematosus
- +2 more
- CNCT19 cell injection
-
Peking, ChinaXiaofeng Zeng
Jul 3, 2023